1. Targeting Cancer Lysosomes with Good Old Cationic Amphiphilic Drugs
    Anne-Marie Ellegaard et al, 2020, Organelles in Disease CrossRef
  2. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
    Carmen Herranz et al, 2021, EMBO Molecular Medicine CrossRef
  3. Loratadine inhibits Staphylococcus aureus virulence and biofilm formation
    Jinxin Zheng et al, 2022, iScience CrossRef
  4. H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
    Yu-Chuan Shen et al, 2022, Journal of Clinical Oncology CrossRef
  5. Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer
    James S. Brown, 2022, Neuroscience & Biobehavioral Reviews CrossRef
  6. Histamine H1 type receptor antagonist loratadine ameliorates oxidized LDL induced endothelial dysfunction
    Yuyang Zhou et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  7. Effects of Albumin–Chlorogenic Acid Nanoparticles on Apoptosis and PI3K/Akt/mTOR Pathway Inhibitory Activity in MDA-MB-435s Cells
    Badr Alzahrani et al, 2023, Nanomaterials CrossRef
  8. Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine
    Ildikó Fritz et al, 2021, Translational Oncology CrossRef
  9. Asymmetric Catalysis upon Helically Chiral Loratadine Analogues Unveils Enantiomer-Dependent Antihistamine Activity
    Elizabeth A. Stone et al, 2020, Journal of the American Chemical Society CrossRef
  10. The antagonistic activity of H1 receptor antagonists as medicinal foods
    Shiyang Zhou et al, 2020, Trends in Food Science & Technology CrossRef
  11. Loratidine is associated with improved prognosis and exerts antineoplastic effects via apoptotic and pyroptotic crosstalk in lung cancer
    Xiwen Liu et al, 2024, Journal of Experimental & Clinical Cancer Research CrossRef
  12. Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates
    Michał Antoszczak et al, 2021, Current Medicinal Chemistry CrossRef
  13. In vitro and in vivo immunotoxicity of PEGylated Cd-free CuInS2/ZnS quantum dots
    Tingting Chen et al, 2020, Nanotoxicology CrossRef
  14. Pre-activation with TLR7 in combination with thioridazine and loratadine promotes tumoricidal T-cell activity in colorectal cancer
    Xiaotan Lin et al, 2020, Anti-Cancer Drugs CrossRef
  15. Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment
    Narjes Hendouei et al, 2019, European Journal of Pharmacology CrossRef
  16. Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial–Mesenchymal Transition and Arousing Immune Response
    Ming Zhang et al, 2024, Journal of Medicinal Chemistry CrossRef